Prestige Wealth Management Group LLC Amgen Inc Transaction History

Prestige Wealth Management Group LLC

$443 Million
Q1 2024

A detailed history of Prestige Wealth Management Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 383 shares of AMGN stock, worth $119,067. This represents 0.02% of its overall portfolio holdings.

Number of Shares

383

Previous 408 6.13%

Holding current value

$119,067

Previous $117,000 7.69%

% of portfolio

0.02%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	SELL	$268.87 - $324.56 $6,721 - $8,114	-25 Reduced 6.13%	383 $108,000
Q4 2023 Apr 26, 2024	SELL	$255.7 - $288.46 $1,534 - $1,730	-6 Reduced 1.45%	408 $117,000
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $1,534 - $1,730	-6 Reduced 1.45%	408 $117,000
Q3 2023 Apr 26, 2024	SELL	$218.65 - $271.46 $24,270 - $30,132	-111 Reduced 21.14%	414 $111,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $24,270 - $30,132	-111 Reduced 21.14%	414 $111,000

Q2 2023 Apr 26, 2024	SELL	$214.27 - $253.37 $334,261 - $395,257	-1,560 Reduced 74.82%	525 $116,000
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $334,261 - $395,257	-1,560 Reduced 74.82%	525 $116,000
Q1 2023 Apr 26, 2024	BUY	$225.79 - $275.2 $384,294 - $468,390	1,702 Added 444.39%	2,085 $504,000
Q1 2023 May 16, 2023	BUY	$225.79 - $275.2 $340,265 - $414,726	1,507 Added 260.73%	2,085 $504,000
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $303,235 - $385,297	-1,324 Reduced 69.61%	578 $151,000
Q3 2022 Nov 01, 2022	BUY	$224.46 - $253.15 $22,670 - $25,568	101 Added 5.61%	1,902 $428,000
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $39,912 - $44,416	173 Added 10.63%	1,801 $438,000
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $279,349 - $309,034	1,274 Added 359.89%	1,628 $393,000
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $1,988 - $2,276	-10 Reduced 2.75%	354 $79,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $33,538 - $39,294	158 Added 76.7%	364 $77,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $35,504 - $39,389	-152 Reduced 42.46%	206 $50,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $3,772 - $4,396	17 Added 4.99%	358 $89,000
Q4 2020 Feb 17, 2021	SELL	$216.38 - $257.67 $143,243 - $170,577	-662 Reduced 66.0%	341 $78,000
Q3 2020 Oct 26, 2020	BUY	$234.65 - $260.95 $26,984 - $30,009	115 Added 12.95%	1,003 $255,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $21,759 - $26,701	110 Added 14.14%	888 $210,000
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $27,153 - $36,013	149 Added 23.69%	778 $158,000
Q4 2019 Jan 28, 2020	SELL	$189.21 - $243.2 $1,135 - $1,459	-6 Reduced 0.94%	629 $152,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $3,656 - $4,381	21 Added 3.42%	635 $123,000
Q2 2019 Aug 16, 2019	BUY	$166.7 - $195.41 $66,513 - $77,968	399 Added 185.58%	614 $113,000
Q1 2019 Aug 16, 2019	SELL	$180.87 - $203.88 $25,683 - $28,950	-142 Reduced 39.78%	215 $41,000
Q4 2018 Apr 16, 2019	BUY	$178.4 - $208.25 $63,688 - $74,345	357 New	357 $69,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.

Account

Prestige Wealth Management Group LLC Amgen Inc Transaction History